recombinant exendin-4 (Uni-E4)
/ Uni-Bio Sci
- LARVOL DELTA
Home
Next
Prev
1 to 14
Of
14
Go to page
1
August 14, 2025
Accessible Type 2 diabetes medication through stable expression of Exendin-4 in Saccharomyces cerevisiae.
(PubMed, Front Syst Biol)
- "In this study, experimental models for recombinant Exendin-4 protein production were designed in both Escherichia coli and Saccharomyces cerevisiae. Protein expression in the chromosomally integrated S. cerevisiae strain was observed at the expected size of Exendin-4 and confirmed by immunoassay. This provides a foundation for the use of this Generally Regarded as Safe organism as an affordable treatment for Type 2 diabetes that can be propagated, prepared, and distributed locally."
Journal • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
June 24, 2024
Candidate anti-tuberculosis medicines and regimens under clinical evaluation.
(PubMed, Clin Microbiol Infect)
- "A large number of potential anti-TB candidate medicines and innovations in clinical trial design for the evaluation of regimens, rather than single medicines, provide hope for improvements in the treatment of TB."
Journal • Review • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis
June 17, 2023
415: UNITE4TB: tuberculosis renewed European Union project
(ERS 2023)
- "Aims: to explain how to use and discuss the methods used to diagnose tuberculosis (TB) and identify resistance; to describe the different drugs and regimens being studied for TB treatment; to explain the advances and challenges in the development of biomarkers; to explain the importance of treatment adherence and the different interventions in use."
Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis
April 11, 2023
"@IgorStojkov_ @DerryMercer @GeraldineJoanny @YojanaGadiya @FernowJosepine @RaquelAFDuarte @SwissButcher74 @IHIEurope @EFPIA @AllianceBEAM @EuropeVaccine @TRIC_TB @UNITE4TB @AMR_Combine @UU_University @lygature @GSK @Evotec @JanssenGlobal @LMU_Muenchen @Bioversys"
(@AMRAccelerator)
Clinical
March 30, 2023
"Deep empathy @fabian_theis quoting @EricTopol at the #UNITE4TB #ERS webnar on AI and Tuberculosis"
(@otavio_ranzani)
Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis
February 22, 2023
"Presenting Work Package Biomarkers at the @UNITE4TB Project Steering Committee in Tres Cantos, Madrid, Spain. Thank you @GSK for hosting us! #tuberculosis #biomarkers"
(@biosquirrel_)
Biomarker • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis
February 16, 2023
"UNITE4TB partners, please help spread the word: @ISPUP, @LaStatale, @lygature, @EuroRespSoc, @TBAlliance, @TBnet_EU, @LMU_Uniklinikum, @DZIF_, @GSK, @JNJNews, @EFPIA, @radboudumc, @OUCRU_Programme, @taskapplied, @FINDdx, @EuropeanLung, @CPathInstitute, @kncvtbc, @UCSF_CTB"
(@UNITE4TB)
January 10, 2023
Production of active Exendin-4 in Nicotiana benthamiana and its application in treatment of type-2 diabetics.
(PubMed, Front Plant Sci)
- "In this study, we report that the GLP-1 analogue recombinant Exendin-4 (Exdn-4) can be produced at a high level in Nicotiana benthamiana, with an estimated yield of 50.0 µg/g fresh biomass. Moreover, Exdn-4 without any extra residues was produced from BGC : Exdn-4 bound onto MCC beads by treating with enterokinase. Plant-produced Exdn-4 (Exendin-4) was as effective as chemically synthesized Exendin-4 in glucose-induced insulin secretion (GIIS) from mouse MIN6m9 cells a pancreatic beta cell line."
Journal • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
August 25, 2022
"#StrongerTogether ! We're proud @IHIEurope @AMRAccelerator project @UNITE4TB is fighting to #ENDTB 💪💊"
(@AMR_Combine)
June 17, 2022
"Unite4Truth deep dive: Bill Gates and the use of "Insecticide Cures" for fake diseases: https://t.co/AoS6IxbXe3"
(@PodcastBill)
March 10, 2022
"Hello @UNITE4TB, welcome to Twitter! 👋🏻"
(@JensJot)
November 16, 2021
"El Dr Barros (@GSK) presenta l’estudi #UNITE4 que compta amb finançament de la @EU_Commission a través del #IMI2 #TallerTB21 @TB_UITB"
(@tbexperimental)
October 24, 2021
UNITE4TB: a new consortium for clinical drug and regimen development for TB.
(PubMed, Int J Tuberc Lung Dis)
- No abstract available
Clinical • Journal
May 13, 2021
"Intriguing during these tumultuous times... @Roche @DrRomie @purviparwani @pjain @MattSakumoto @Karthik28930366 #unite4india"
(@MamtaSwa)
1 to 14
Of
14
Go to page
1